Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 1
Submit an article Journal homepage
3,622
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method

David Z. Nga Internal Medicine Residency, SingHealth Services, SingaporeView further author information
,
Chuan Yaw Leea Internal Medicine Residency, SingHealth Services, SingaporeView further author information
,
Winnie W. Lamb Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore;c Duke-NUS Medical School, Radiological Sciences Academic Clinical Programme, SingaporeORCID Iconhttps://orcid.org/0000-0002-9813-9857View further author information
ORCID Icon,
Aaron K. Tongb Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore;c Duke-NUS Medical School, Radiological Sciences Academic Clinical Programme, SingaporeView further author information
,
Sze Huey Tand Biostatistics Unit, National Cancer Centre Singapore, SingaporeView further author information
,
Lay Poh Khooe Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Ya Hwee Tane Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Jianbang Chiange Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Esther W. Change Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Jason Y. Chane Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, SingaporeView further author information
,
Eileen Y. Poone Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Nagavalli Somasundarame Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Mohamed Farid H. Rashide Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Miriam Taoe Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
,
Soon Thye Lime Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, SingaporeView further author information
&
Valerie S. Yange Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, Singapore;g Translational Precision Oncology Laboratory, Institute of Molecular & Cell Biology, A*STAR, SingaporeCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8844-9421View further author information
ORCID Icon show all
Pages 256-259 | Received 13 Jun 2021, Accepted 28 Sep 2021, Published online: 19 Oct 2021

References

  • Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008;9(2):105–116.
  • Schmitz C, Hüttmann A, Müller SP, et al. Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: post-hoc analysis from the PETAL trial. Eur J Cancer. 2020;124:25–36.
  • Duarte S, Afonso C, Marques B, et al. Survival independent predictive value of INTERIM FDG 18‐PET in newly diagnosed diffuse large B cell lymphoma. Hematol Oncol. 2021;39(S2):39.
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the lugano classification. J Clin Oncol. 2014;32(27):3059–3067..
  • Han EJ, O JH, Yoon H, et al. FDG PET/CT response in diffuse large B-cell lymphoma: reader variability and association with clinical outcome. Medicine. 2016;95(39):e4983.
  • Itti E, Meignan M, Berriolo-Riedinger A, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. Eur J Nucl Med Mol Imaging. 2013;40(9):1312–1320.
  • Rekowski J, Hüttmann A, Schmitz C, et al. Interim PET evaluation in diffuse large B-cell lymphoma using published recommendations: comparison of the Deauville 5-point scale and the ΔSUVmax method. J Nucl Med. 2021;62(1):37–42.
  • Eertink JJ, Burggraaff CN, Heymans MW, et al. Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood Adv. 2021;5(9):2375–2384.
  • Maurer MJ, Ghesquières H, Jais J-P, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-Cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066–1073.
  • Casasnovas R-O, Meignan M, Berriolo-Riedinger A, et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood. 2011;118(1):37–43.
  • Hans CP. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282.
  • Wilcox RA, Ristow K, Habermann TM, et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia. 2011;25(9):1502–1509.
  • Adams HJA, Kwee TC. Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients. Ann Hematol. 2020;99(1):1–5.
  • Barrington S, Eertink JJ, de Vet HC, et al. Not yet time to abandon the Deauville criteria in diffuse large B cell lymphoma. J Nucl Med. 2021;jnumed.121.262317. https://jnm.snmjournals.org/content/early/2021/04/23/jnumed.121.262317/tab-article-info

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.